Literature DB >> 2693748

Tissue-chamber modeling systems--applications in veterinary medicine.

C R Clarke1.   

Abstract

Mesh：

Year:  1989        PMID： 2693748     DOI： 10.1111/j.1365-2885.1989.tb00686.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN： 0140-7783            Impact factor:   1.786


× No keyword cloud information.
  6 in total

1.  Pharmacokinetic evaluation of ceftiofur in serum, tissue chamber fluid and bronchial secretions from healthy beef-bred calves.

Authors:  S L Halstead; R D Walker; J C Baker; R E Holland; G E Stein; J G Hauptman
Journal:  Can J Vet Res       Date:  1992-10       Impact factor: 1.310

2.  Effects of localized Pasteurella haemolytica infection on erythromycin-binding properties of bovine alpha-1-acid glycoprotein, albumin, serum, and tissue chamber fluids.

Authors:  J L Walker; C R Clarke; C M Hague; D W Bourne; B A Lessley
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

3.  Use of a rabbit soft tissue chamber model to investigate campylobacter jejuni-host interactions.

Authors:  Annika Flint; James Butcher; Cyril Clarke; Denver Marlow; Alain Stintzi
Journal:  Front Microbiol       Date:  2010-11-16       Impact factor: 5.640

4.  Tissue chambers--a useful model for in vivo studies of cytokine production in the pig.

Authors:  E Wattrang; P Wallgren; L Fuxler; M Lindersson; C Fossum
Journal:  Vet Immunol Immunopathol       Date:  1997-05       Impact factor: 2.046

5.  In vivo antimicrobial activity of marbofloxacin against Pasteurella multocida in a tissue cage model in calves.

Authors:  Changfu Cao; Ying Qu; Meizhen Sun; Zhenzhen Qiu; Xianhui Huang; Binbin Huai; Yan Lu; Zhenling Zeng
Journal:  Front Microbiol       Date:  2015-07-24       Impact factor: 5.640

6.  Ceftiofur formulation differentially affects the intestinal drug concentration, resistance of fecal Escherichia coli, and the microbiome of steers.

Authors:  Derek M Foster; Megan E Jacob; Kyle A Farmer; Benjamin J Callahan; Casey M Theriot; Sophia Kathariou; Natalia Cernicchiaro; Timo Prange; Mark G Papich
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.